83 related articles for article (PubMed ID: 1532669)
1. Modulation of fluoropyrimidines: role of dose and schedule of leucovorin administration.
Zhang ZG; Harstrick A; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):10-5. PubMed ID: 1532669
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms.
Zhang ZG; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 4):46-50. PubMed ID: 1532459
[TBL] [Abstract][Full Text] [Related]
3. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
Cao S; Frank C; Rustum YM
J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
[TBL] [Abstract][Full Text] [Related]
4. Effects of diastereoisomers of 5-formyltetrahydrofolate on cellular growth, sensitivity to 5-fluoro-2'-deoxyuridine, and methylenetetrahydrofolate polyglutamate levels in HCT-8 cells.
Zhang ZG; Rustum YM
Cancer Res; 1991 Jul; 51(13):3476-81. PubMed ID: 2054787
[TBL] [Abstract][Full Text] [Related]
5. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
[TBL] [Abstract][Full Text] [Related]
6. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
7. [Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group].
Sugano K; Ota K; Taguchi T; Ogawa N; Kurihara M; Akazawa S; Ogawa M; Tominaga T; Sasaki T; Konishi T
Gan To Kagaku Ryoho; 1995 Apr; 22(5):627-37. PubMed ID: 7717714
[TBL] [Abstract][Full Text] [Related]
8. Rationale for treatment design: biochemical modulation of 5-fluorouracil by leucovorin.
Rustum YM; Cao S; Zhang Z
Cancer J Sci Am; 1998; 4(1):12-8. PubMed ID: 9467039
[TBL] [Abstract][Full Text] [Related]
9. [High-dose leucovorin and 5-FU].
Sasaki T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):954-62. PubMed ID: 1626951
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effect and characteristics of low dose leucovorin and high dose 5-FU therapy in patients with recurrent gastric cancer--a new method of biochemical modulation].
Kajiyama Y; Tsurumaru M; Ono Y; Udagawa H; Watanabe G; Suzuki M; Matsuda M; Akiyama H
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1797-801. PubMed ID: 8379672
[TBL] [Abstract][Full Text] [Related]
11. [Phase I study of 5-fluorouracil and l-leucovorin].
Sasaki T; Ota K; Wakui A; Akazawa S; Ogawa M; Ariyoshi Y; Yura J; Inagaki J; Hoshino A; Abe T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):485-91. PubMed ID: 8452386
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
13. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
14. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
Grem JL
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
[TBL] [Abstract][Full Text] [Related]
16. Biochemical modulation of combined radiation and 5-fluorouracil treatment of murine tumors by d,l-leucovorin.
Kovacs CJ; Dainer PM; Evans MJ; Nyce J
Anticancer Res; 1991; 11(2):905-9. PubMed ID: 2064349
[TBL] [Abstract][Full Text] [Related]
17. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
[TBL] [Abstract][Full Text] [Related]
18. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical modulation of 5-fluorouracil by high-dose leucovorin].
Aiba K
Gan To Kagaku Ryoho; 1988 Mar; 15(3):392-408. PubMed ID: 3279911
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of resistance to fluoropyrimidines.
Zhang ZG; Harstrick A; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):4-9. PubMed ID: 1532673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
